An updated review of immune checkpoint inhibitors in cutaneous oncology: Beyond melanoma
James P. Pham(St Vincent's Clinic), Simone M. Goldinger(Melanoma Institute Australia), Anthony M. Joshua(University Health Network), Jia Liu(The University of Sydney), R. Dummer(University Hospital of Zurich), Inês Pires da Silva(The University of Sydney), Ramon Staeger(University Hospital of Zurich)
Cited by 12
Related Papers
Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
|New England Journal of Medicine|2014|3k
Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma
|New England Journal of Medicine|2021|869
Niraparib and Abiraterone Acetate for Metastatic Castration-Resistant Prostate Cancer
|Journal of Clinical Oncology|2023|317
Machine learning for multi-omics data integration in cancer
|iScience|2022|298